Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
April 20, 2020 Cover
Volume 98, Issue 15
The presence of the probable carcinogen has prompted drugmakers to issue recall after recall. What risk does it pose, what’s the chemistry behind it, and how are drugmakers going to stop the contamination?
Cover image:The presence of the potential carcinogen NDMA in common drugs has triggered waves of recalls. What are drugmakers doing to address the problem?
Credit: Chris Gash
NDMA, a contaminant found in multiple drugs, has industry seeking sources and solutions
The presence of the probable carcinogen has prompted drugmakers to issue recall after recall. What risk does it pose, what’s the chemistry behind it, and how are drugmakers going to stop the contamination?
How peracetic acid is changing wastewater treatment
A new disinfection chemistry holds environmental and financial promise
What do we know about the novel coronavirus’s 29 proteins?
These biomolecules could hold clues to why the virus is so infectious and how to stop it
-
Consortia lend their supercomputers to fight COVID-19
National labs, universities, and companies around the world are fast-tracking proposals to use their high-performance computer resources against the novel coronavirus
-
Get ready for a potential chemistry job crisis
Whatever COVID-19 does to chemical employment, it’s wise to start preparing your career emergency kit
-
Environmental toxicologist wants to understand how microplastics affect human health
Stephanie Wright of King’s College London discusses what’s known about microplastics and how much more there is to learn
ADVERTISEMENT
Science Concentrates
COVID-19 vaccines are moving toward clinical trials
Tests of 10 or more novel vaccines could be underway by mid-May
Business & Policy Concentrates
- Chemical outlook post COVID-19 is bleak
- Disinfectant demand from coronavirus concerns challenges specialty chemical supply chain
- US EPA won’t strengthen particulate matter limit
- Industry requests safety review of cyclic siloxane
- How industrial gas firms are meeting demand for medical oxygen for COVID-19 patients
